Hamada, S., Matsumoto, R., Tanaka, Y., Taguchi, K., Yamamoto, M., & Masamune, A. (2021). Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. Int J Mol Sci.
Dyfyniad Arddull ChicagoHamada, Shin, Ryotaro Matsumoto, Yu Tanaka, Keiko Taguchi, Masayuki Yamamoto, and Atsushi Masamune. "Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition." Int J Mol Sci 2021.
Dyfyniad MLAHamada, Shin, et al. "Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition." Int J Mol Sci 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.